UPDATE: Biogen Idec Posts Higher Q4 Profit

Biogen Idec BIIB reported a 57% rise in its fourth-quarter profit. Biogen Idec's quarterly net profit surged to $457.3 million, or $1.92 per share, versus $292.1 million, or $1.23 per share, in the year-ago period. Excluding one-time items, it earned $2.34 per share, versus analysts' estimates of $2.28 per share. Its total sales climbed 39% to $1.97 billion, versus analysts' estimates of $1.93 billion. Biogen Idec shares closed at $305.65 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsprofit
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!